Please select one of the following:
DECLARATION OF CONSENT
The Bayer AG wishes to use your email address to periodically send you a newsletter containing information and company news related to CKD, and to subsequently analyze your use of these newsletters, to be able to adjust its content to your interests. For respective details, including information on how you may revoke your consent at any time, please see our Privacy Statement.
CKD: chronic kidney disease; T2D: type 2 diabetes.
© 2021 Bayer Pharmaceuticals, Inc. All rights reserved.
BAYER and the Bayer Cross are registered trademarks of Bayer.
Last updated 03/21
This site is intended for US healthcare professionals only.